Amphastar Pharmaceuticals Inc (AMPH)
48.02
+0.14
(+0.29%)
USD |
NASDAQ |
Sep 27, 16:00
47.98
-0.04
(-0.08%)
After-Hours: 20:00
Amphastar Pharmaceuticals Revenue (Annual): 644.40M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 644.40M |
| December 31, 2022 | 498.99M |
| December 31, 2021 | 437.77M |
| December 31, 2020 | 349.85M |
| December 31, 2019 | 322.36M |
| December 31, 2018 | 294.67M |
| December 31, 2017 | 240.18M |
| Date | Value |
|---|---|
| December 31, 2016 | 255.16M |
| December 31, 2015 | 251.52M |
| December 31, 2014 | 210.46M |
| December 31, 2013 | 229.68M |
| December 31, 2012 | 204.32M |
| December 31, 2011 | 118.36M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
322.36M
Minimum
2019
644.40M
Maximum
2023
450.67M
Average
437.77M
Median
2021
Revenue (Annual) Benchmarks
| Omeros Corp | -- |
| Harrow Inc | 130.19M |
| PetIQ Inc | 1.102B |
| Amneal Pharmaceuticals Inc | 2.394B |
| Alector Inc | 97.06M |